Biden-picked Bubs Australia (ASX:BUB) pivots to America, offsetting China’s demand weighed down by months of Covid-19 lockdowns.
Bub’s infant formula is set to hit the shelves this month after a major recall of several baby products on reports of bacterial infections in four babies – two of whom died in America.
The US has been grappling with a nation-wide shortage after a contamination scare which involved its largest formula manufacturer, Abbott, leading to a shut down of its Michigan plant.
This morning the Biden administration unveiled its fourth operation fly formula mission to transport the first two deliveries of Bubs infant formula products. The first flights are slated to take-off from Melbourne next Thursday and Friday, 9 and 11 June respectively.
Meanwhile, Australian Dairy Nutritionals group (ASX:AHF) have flagged to investors that wheels are in motion with the US FDA to be considered to help with the infant formula shortfall.
Shares in Bubs Australia (ASX:BUB) closed at 58 cents yesterday. Australian Dairy Nutritionals group (ASX:AHF) closed at 7.9 cents.